Last reviewed · How we verify
NCT02219308
Pain Control for Intrauterine Device Placement: A Randomized Controlled Trial of Paracervical Block
NA trial testing Paracervical Block (PCB) in Pain Due to Intrauterine Contraceptive Device in 67 participants. Completed in 1 October 2017.
1 October 2017
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 67 |
| Start date | 1 October 2014 |
| Primary completion | 1 October 2017 |
| Estimated completion | 1 October 2017 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Paracervical Block (PCB)
- No Paracervical Block (Sham PCB)
Conditions studied
- Pain Due to Intrauterine Contraceptive Device — all drugs for Pain Due to Intrauterine Contraceptive Device →
Sponsor
University of California, San Diego
Who can join
Adults 18 to 45, female only, with Pain Due to Intrauterine Contraceptive Device. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Pain With Intrauterine Device (IUD) Placement
Time frame: Moment of IUD insertion
Distance (mm) from the left of the 100-mm visual analog scale (reflecting magnitude of pain) recorded at time of IUD Placement. Scale range is from 0mm (no pain) to 100mm (worst pain possible). A lower score (less pain) is considered a better outcome.
Sponsor's own description
Intrauterine device (IUD) placement can be painful for patients during and after the procedure. Fear of pain from IUD insertion can be a barrier to obtaining this highly effective long acting reversible contraception. Currently there are no proven effective methods for reduction of pain during and after placement of modern IUDs. Paracervical block pain may decrease this placement pain.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial.
Mody SK, Farala JP, Jimenez B, Nishikawa M, et al · · 2018 · cited 44× · PMID 30095776 · DOI 10.1097/aog.0000000000002790
Verify or expand the search:
- PubMed search for NCT02219308
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02219308 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 10 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02219308.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing